Quince Therapeutics (QNCX) P/E (2019 - 2026)
Quince Therapeutics (QNCX) P/E from May 9, 2019 to Jul 21, 2026. The TTM Quince Therapeutics (QNCX) P/E is -1.89. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Quince Therapeutics (QNCX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.89 | -95.50% |
| 2025 | -42.01 | +47.00% |
| 2024 | -28.58 | +5.12% |
| 2023 | -27.18 | +363.87% |
| 2022 | -5.86 | -92.99% |
| 2021 | -83.60 | -60.78% |
| 2020 | -213.17 | -74.85% |
| 2019 | -847.48 | N/A |
Comparison Quince Therapeutics (QNCX) P/E with competitors
Quince Therapeutics (QNCX) P/E is -1.89.